Celsense, Inc. (CMU) Completes Sale of Series C Shares (11/2/2010)

Celsense develops novel MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company was founded by Eric T. Ahrens, Ph.D., who is an associate professor at CMU.

Celsense, Inc. announced that it has completed a sale of Series C Convertible Preferred Stock. Proceeds from the financing transaction totaled $1,744,000. Purchasers of the Series C included current stockholders, new individual investors, and the Pittsburgh Life Science Greenhouse. read more


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: